Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review

MLA

Ricvan Dana Nindrea, et al. “Comparing the Effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in Heart Failure Patients with Type 2 Diabetes Mellitus: A Systematic Review.” Bali Medical Journal, vol. 8, Dec. 2019, pp. 757–61. EBSCOhost, https://doi.org/10.15562/bmj.v8i3.1534.

APA

Ricvan Dana Nindrea, Iwan Dwiprahasto, Ratih Puspita Febrinasari, Bambang Irawan Martohusodo, & Erna Kristin. (2019). Comparing the effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in heart failure patients with type 2 diabetes mellitus: a systematic review. Bali Medical Journal, 8, 757–761. https://doi.org/10.15562/bmj.v8i3.1534

Chicago

Ricvan Dana Nindrea, Iwan Dwiprahasto, Ratih Puspita Febrinasari, Bambang Irawan Martohusodo, and Erna Kristin. 2019. “Comparing the Effect of Angiotensin-Converting Enzyme Inhibitors versus Angiotensin Receptor Blockers in Heart Failure Patients with Type 2 Diabetes Mellitus: A Systematic Review.” Bali Medical Journal 8 (December): 757–61. doi:10.15562/bmj.v8i3.1534.